000 04019cam a2200865 a 4500
001 ocn794306445
003 OCoLC
005 20171114091329.0
006 m o d
007 cr un|---uuuuu
008 120524s2013 nju ob 001 0 eng
010 _a 2012021594
020 _a9781118356791
_q(epub)
020 _a1118356799
_q(epub)
020 _a9781118356784
_q(pdf)
020 _a1118356780
_q(pdf)
020 _a9781118356777
_q(mobi)
020 _a1118356772
_q(mobi)
020 _a9781118356807
_q(electronic bk.)
020 _a1118356802
_q(electronic bk.)
020 _a1118338731
_q(hardback)
020 _a9781118338735
_q(hardback)
020 _a9781283893329
_q(MyiLibrary)
020 _a1283893320
_q(MyiLibrary)
020 _z9781118338735
_q(hardback)
020 _z9780470924310
028 0 1 _aEB00063428
_bRecorded Books
029 1 _aAU@
_b000049174758
029 1 _aAU@
_b000051598313
029 1 _aCHBIS
_b010131694
029 1 _aCHVBK
_b314708642
029 1 _aDEBBG
_bBV041049248
029 1 _aDEBBG
_bBV041911084
029 1 _aDEBBG
_bBV042793802
029 1 _aDEBSZ
_b431284571
029 1 _aDKDLA
_b820120-katalog:000600431
029 1 _aNZ1
_b14976917
029 1 _aAU@
_b000058067149
029 1 _aDEBBG
_bBV043394564
035 _a(OCoLC)794306445
_z(OCoLC)864911054
_z(OCoLC)961529634
_z(OCoLC)962708682
_z(OCoLC)966220265
040 _aDLC
_beng
_epn
_cDLC
_dYDX
_dN$T
_dMHW
_dYDXCP
_dCUS
_dSTF
_dCCO
_dIDEBK
_dCOO
_dE7B
_dOCLCF
_dRECBK
_dNLGGC
_dDEBSZ
_dOCLCQ
_dOCLCO
_dOCLCQ
_dDEBBG
_dAZK
_dOCLCQ
_dLOA
_dOCLCO
_dOCLCA
042 _apcc
049 _aMAIN
050 4 _aQP99.3.P7
_bP76 2013
060 1 0 _aWH 400
072 7 _aMED
_x071000
_2bisacsh
082 0 0 _a615.3/9
_223
245 0 0 _aProduction of plasma proteins for therapeutic use /
_cedited by Joseph Bertolini, Neil Goss, and John Curling.
_h[electronic resource]
260 _aHoboken, N.J. :
_bJohn Wiley & Sons,
_c©2013.
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _adata file
_2rda
380 _aBibliography
504 _aIncludes bibliographical references and index.
505 0 _aSection 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation.
520 _aA comprehensive compilation on plasma protein production from the leading experts in the field, Production of Plasma Proteins for Therapeutic Use presents manufacturing, testing methods, and regulatory issues for plasma-derived therapeutics, a global US10 billion industry. Culling material that until now have only been available in scattered forms across journals and books, the text features twenty-three detailed protein-by-protein chapters written by the major manufacturers of plasma protein products, addressing all aspects of these proteins, including biology, clinical use, manufactu.
588 0 _aPrint version record and CIP data provided by publisher.
650 0 _aBlood proteins
_xTherapeutic use.
650 2 _aBlood Proteins
_xtherapeutic use.
650 2 _aBlood Proteins
_xchemical synthesis.
650 2 _aChemical Fractionation.
650 4 _aMedical.
650 7 _aMEDICAL
_xPharmacology.
_2bisacsh
650 7 _aBlood proteins
_xTherapeutic use.
_2fast
_0(OCoLC)fst00834823
655 4 _aElectronic books.
655 7 _aElectronic books.
_2local
700 1 _aBertolini, Joseph.
700 1 _aGoss, Neil.
700 1 _aCurling, J. M.
_q(John M.)
776 0 8 _iPrint version:
_tProduction of plasma proteins for therapeutic use.
_dHoboken, N.J. : John Wiley & Sons, ©2013
_z9781118338735
_w(DLC) 2012020857
856 4 0 _uhttp://onlinelibrary.wiley.com/book/10.1002/9781118356807
_zWiley Online Library
942 _2ddc
_cBK
999 _c205926
_d205926